Heather E. Wheeler Discusses Cisplatin-Induced Hearing Loss
Heather E. Wheeler, assistant professor of Biology and Computer Science at Loyola University Chicago, discusses genetic factors that may lead to hearing loss in patients with testicular cancer who are on cisplatin.
Heather E. Wheeler, assistant professor of Biology and Computer Science at Loyola University Chicago, discusses genetic factors that may lead to hearing loss in patients with testicular cancer who are on cisplatin.
Wheeler compared patients' genomes with level of hearing loss and found that those with a mutation in the WFS1 gene had an increased tendency to lose hearing to some degree. Interestingly, mutations in that gene also cause Wolfram Syndrome, which shows itself in many ways, including deafness. Now that there is a genetic correlation helping to explain cisplatin-induced hearing loss, Wheeler hopes that ways to prevent the malady can be developed.
Oncology Nurses Provide Patients an Avenue to Supportive Care
November 12th 2019Palliative care is often associated with a patient entering end of life treatment and giving up on their treatment, but that isn't the reality of what id can do for patients. And oncology nurses can help guide patients to the right supportive care for them.
Hyman B. Muss Discusses the Importance of Nurses in Treating Pregnant Women With Breast Cancer
March 23rd 2016Hyman B. Muss, MD, professor of medicine at the University of North Carolina School of Medicine, discusses the vital roles that nurses play when it comes to treating pregnant women with breast cancer.
Kimberly J. Van Zee on Nomograms Helping in DCIS Treatment Decision-Making
March 18th 2016Kimberly J. Van Zee, MS, MD, FACS, attending surgeon at Memorial Sloan Kettering Cancer Center, discusses the institution's newly-developed nomogram that can help women make treatment decisions about ductal carcinoma in situ (DCIS).
